 |
Joele Frank and ICR Healthcare are working the $1.1B deal by GHO Capital Partners and Ampersand Capital Partners to take Avid Bioservices private.
The $12.50 per share offer represents a 22 percent premium to Avid’s 20-day average stock price.
After considering alternatives, Avid’s board determined that the bid “provides stockholders significant, immediate and certain cash value for their shares,” according to Nick Green, Avid’s CEO.
Partnering with Ampersand and GHO “allows us to build on our strong foundation by accessing their significant knowledge base, network and capital to position the business for the future with our customers,” he added.
Avid, which is based in Tustin, CA, provides manufacturing services for the biotechnology and biopharmaceutical sectors.
ICR Healthcare’s Amber Fennell and Kris Lam represent London-based GHO.
Joele Frank, Wilkinson, Brimmer Katcher’s Aaron Palash and Allison Sobel handle media for Avid, while Vida Strategic Partners works the investment beat.
Prosek Partners handles New York’s Tilray Brands, craft beer & cannabis operation, as it acquires BrewDog, a leading British independent beer producer in the UK, for $45M.
Brunswick Group handles Zurich Insurance as it agrees to buy UK-based Beazley specialty insurer in a deal valued at $11B.
FGS Global represents Brink’s as it agrees to acquire NCR Atleos, which relies on Collected Strategies, in a $6.6B cash & stock deal to create a leading fintech infrastructure company. (Updated)
A January article in O’Dwyer’s proposes that in 2026, the strongest financial brands will not simply tell compelling stories—they will “signal readiness.”
C Street Advisory Group is working the Chapter 11 filing of Axip Energy Services as it unloads its nearly all of its assets to deal with a heavy debt load.
